Variable | All cases | Overall survival (months) | χ2 | P valuea | |
---|---|---|---|---|---|
Mean | Media | ||||
Age (years) | 0.12 | 0.73 | |||
≤ 60 | 14 | 36.7 | 23.0 | ||
> 60 | 45 | 45.7 | 43.0 | ||
Gender | 0.01 | 0.98 | |||
Male | 50 | 45.0 | 39.0 | ||
Female | 9 | 33.9 | 17.0 | ||
Tumor size (cm) | 0.47 | 0.50 | |||
≤ 5 | 37 | 37.4 | 25.0 | ||
> 5 | 22 | 49.9 | 63.0 | ||
Differentiation | 2.80 | 0.09 | |||
I-II | 20 | 48.9 | 40.0 | ||
III-IV | 39 | 38.6 | 24.0 | ||
T stage | 8.11 | 0.01 | |||
T1-T2 | 33 | 51.1 | 39.0 | ||
T3-T4 | 26 | 31.5 | 17.0 | ||
N stage | 1.82 | 0.18 | |||
N0 | 37 | 47.2 | 43.0 | ||
N1-N2 | 22 | 24.3 | 25.0 | ||
AJCC stage | 6.50 | 0.01 | |||
I-II | 34 | 48.9 | 38.0 | ||
III-IV | 25 | 31.9 | 20.0 | ||
SIRT4 levels | 8.58 | 0.01 | |||
High | 38 | 47.5 | 37.0 | ||
Low | 21 | 27.9 | 24.0 |